{
  "pmcid": "1388093",
  "sha256": "560a37db7a9d4221f3ea373c166765b09fd7614331496ce0168398792bc0b62b",
  "timestamp_utc": "2025-11-09T15:46:53.113420+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.655639810426546,
    "reading_ease": 40.40626686110102,
    "word_count": 211
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomly assigned"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomly assigned to receive an initial bolus of 0.5 mg/kg ketamine followed by a continuous infusion of 3 μg·kg -1 ·min -1 during surgery and 1.5 μg·kg -1 ·min -1 for 48 h (Ketamine group) or an equal volume of saline (Control group)."
      },
      "Objective": {
        "score": 1,
        "evidence": "We designed this study to evaluate the effect of small-dose intravenous ketamine in combination with continuous femoral nerve block on postoperative pain and rehabilitation after total knee arthroplasty."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Pain scores and morphine consumption were recorded over 48 hours."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients were randomly assigned"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The Ketamine group required significantly less morphine than the Control group (45 ± 20 mg versus 69 ± 30 mg; P < 0.02). Patients in the Ketamine group reached 90° of active knee flexion more rapidly than those in the Control group ( P < 0.02)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 9,
    "max_score": 25
  }
}